Beacon Investment Advisory Services, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Beacon Investment Advisory Services, Inc.
- $2.29 Billion
- Q4 2024
A detailed history of Beacon Investment Advisory Services, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 24,508 shares of REGN stock, worth $17.1 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
24,508
Previous 27,186
9.85%
Holding current value
$17.1 Million
Previous $28.6 Million
38.92%
% of portfolio
0.76%
Previous 1.2%
Shares
19 transactions
Others Institutions Holding REGN
# of Institutions
1,496Shares Held
82.9MCall Options Held
1.22MPut Options Held
1.5M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.5 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.89 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.22 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.42 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...